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SUMMARY
Viruses are the most abundant entities in the biosphere, the estimated amount of
viruses is more than 1030. The number is incomprehensible and exceeds the amount of
host cells at least by one order of magnitude. Viruses are extremely diverse entities by
means of morphologies, sizes, genomes and biochemical and biophysical properties. As
obligate parasites, viruses can only be propagated in living cells. This sets challenges for
the virus purification, since the starting material contains host and growth media
derived impurities. Medical applications such as phage therapy, vaccine development,
and gene therapy require large amounts of highly purified viruses and virus-like
particles (VLPs). Nanotechnology utilizes viruses and VLPs as building blocks for
nanoscale materials and devices and also requires virus purification methods which
maintain the biophysical and biochemical properties of the particles.
Viruses are often purified with combinations of different methods. The most common
ones are precipitation and ultracentrifugation. Precipitation does not lead into high
purities and is generally applied as a pre-step for purification. Ultracentrifugation leads
to high purity but it exposes viruses to high shear forces possibly leading to losses of
infectivity. The large size of many viruses may restrict utilization of traditional
chromatography. However, monolithic matrices are applicable for virus purification.
In this work asymmetrical flow field-flow fractionationation (AF4) method was
developed for virus purification. AF4 is a highly versatile size-based separation method
applicable for samples with sizes ranging between ~1?500 nm. The separation in AF4 is
conducted with the aid of liquid flows. Solid stationary phase is not applied at all, thus
no strong interactions during the separation occur making the method gentle. Several
parameters in the AF4 system are adjustable, making the method highly versatile and
an attractive alternative for virus purification.
In this study, AF4 conditions were optimized for purification of six prokaryotic viruses,
having different morphologies and properties. Analytical sample channel and
preparative UV-detector were utilized. Yields of infective viruses were high and purity
levels  comparable  to  the  ones  obtained  with  a  method  based  on  precipitation  and
ultracentrifugation. AF4 was proven to be applicable for all tested viruses, also the ones
requiring high ionic strength conditions were amenable for AF4 purification. The AF4-
method is fast and obtained virus preparations were homogenous. As the system is
highly versatile, it is expected that it can be tailored for other viruses as well, to meet
the further needs of virus purification.
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11. Introduction
1.1. Viruses
Viruses are contradictory entities in the field of microbes. They are obligate parasites
of cells, yet they do not fill all the classical hallmark features set for living organisms.
Their  replication  occurs  only  in  living  cells,  with  the  aid  of  host  factors,  but  when
released to cell surroundings, viruses are inert vessels protecting the genome and
carrying it to the next host cell. This contrast between intracellular and extracellular
stages of virus replication cycle has led scientists to an everlasting debate of viruses
being living entities or not (Forterre 2016). All cellular organisms have double-stranded
DNA genomes, whereas viruses may contain genomes comprised of double- or single-
stranded DNA or RNA. Additionally, the genome can be circular, linear or segmented
and RNA genomes can be either positive- or negative-sense (Baltimore 1971).
To date the number of complete virus genomes in the database of National Centre for
Biotechnology Information (NCBI) is about 8,000, even though the number of viruses
at our planet is assumed to be astronomical. Oceans are estimated to contain more
than ~1030 viruses (Suttle 2007) and the estimates for virus amounts in soils are
comparable or even higher (Srinivasiah et al. 2008). Thus the number of viruses seems
to exceed the number of host cells by at least 10 times (Bamford 2003; Srinivasiah et
al. 2008; Suttle 2007). Based on these numbers, and the observation that many viral
genes  have  no  homologs,  it  could  be  stated  that  viral  genomes  are  still  the  most
unexplored nature reservoir of genetic information (Yin and Fischer 2008). Additionally,
viruses come in tremendous variations of size, shape and other biochemical and
biophysical properties (chapter 1.2.).
The role of viruses in the biosphere is inevitable. They control population dynamics, as
more than 90% of the living biomass in seas is comprised of microbes, and ~20% of
them  are  killed  daily  by  viruses  (Suttle  2007).  Viruses  in  soils  have  not  yet  been
thoroughly  explored.  Nevertheless,  it  is  estimated  that  majority  of  them  are
bacteriophages, i.e. viruses of bacteria (Williamson et al. 2017). Virus-induced host lysis
plays a major role in the nutrition cycles by releasing contents of infected cells to their
surroundings. Indeed, in both aqueous as well as soil environment, top-down control
of microbial population, and occurrence of virus shunt has been proposed (Suttle
2005). Virus shunt refers to cycling of the organic matter, especially carbon, stemming
from the viral lysis of microbes to environment as pools of dissolved and particulate
organic material, free for consumption (Wilhelm and Suttle 1999).
2As viruses are significant in ecological processes, they also are the driving force for
evolution. Genetic material is often horizontally transferred from the host cell to
another via transduction by progeny viruses (Canchaya et al. 2003). Additionally, the
ability of hosts to restrict virus infections and viruses evolving ways to counteract the
restriction gives rise to coevolution of viruses and their hosts (Forterre and Prangishvili
2009). Overall, the role of viruses in maintaining diversity of host population as well as
modulating the environment is highly important but due the complex nature of
ecosystems, not yet completely understood.
Viruses are causative agents of diseases in animals and plants, having major effects in
lives of people as well as in crop yields and well-being of livestock. Viral diseases in
human range from mild to severe, have a huge load on the healthcare system, and
enormous economic effects. The estimated burden of influenza in U.S. during the
season 2017?2018 reveals high numbers: 23,000,000 medical visits, 960,000
hospitalizations and 79,000 deaths (Center for Disease Control and Prevention). Viruses
pose threats also to the agriculture and food production. Corn is amongst the most
cultivated crops globally (Food and Agriculture Organization of United Nations). It is
cultivated and consumed at all continents and considered as a major staple food in
Africa (Ranum et al. 2014). The most important pathogenic virus of corn is maize dwarf
mosaic virus. It is epidemic globally and has caused 70% losses in corn yields since 1960
(Kannan et al. 2018). Virus infections decrease food production but also compromises
food safety in the case of zoonotic diseases. Foot-and-mouth disease is one of the most
devastating virus diseases of cloven-hoofed animals (Grubman et al. 2008). During
outbreaks, foot-and-mouth disease forces to mass slaughters of animals, restrictions in
animal transportation and exportation of live animals as well as meat products, thus
leading to enormous economic losses (Prempeh et al. 2001).
Even though the headlines about viruses focus on life-threatening disease outbreaks,
viruses are also beneficial, thus playing a dual role in science and society. Infection with
certain viruses may prevent simultaneous infection with pathogenic bacteria. Mice
infected with herpesvirus are protected against Listeria monocytogenes and Yersinia
pestis that are pathogens behind food borne illness and plaque, respectively (Barton et
al. 2007). In a complex three-way mutualistic symbiosis between a grass, fungus and
virus,  the  virus  offers  thermotolerance  for  the  plant  allowing  it  to  grow  at  soil
temperatures higher than 50 °C (Redman et al. 2002). In addition, intestinal viruses are
able to substitute some of the beneficial functions of intestinal bacteria in cases when
they are absent (Kernbauer et al. 2014).
Since current knowledge of viruses is still  only a tip of an ice berg of all  what is out
there, one can only imagine what kind of findings will be unveiled when scientists
3continuously dig deeper to the universe of viruses. Cumulating knowledge of viruses,
their properties and different roles are enabling scientists to harness viruses to work
for us. Several fields of science are already utilizing viruses in one way or another and
after a short introduction to virus sizes, properties and life cycles, I will present few of
these application (chapter 1.6).
1.2. Properties of virus particles
Martin Beijerinck found viruses when he repeated experiments of Adolf Mayer and
filtrated fluids from diseased tobacco plants in 1898. He observed that filtered fluid was
infectious and the infectious agent multiplied in living cells. Beijerinck defined that
viruses are entities that are filterable through pores smaller than bacterial cells (Bos
2000) that typically range between 0.5?5 μm. In recent years, however, the definition
of virus has been challenged and virus diversity has been expanded by characterization
of gigantic viruses. The first giant virus, mimivirus (for ‘mimicking microbes’), was
isolated in 2003 from ameba culture (La Scola et al. 2003). It is ~400 nm in size with ~80
nm fibrils extending from the capsid. Since that the size record holder of giant viruses
to  date  is  pithovirus  sibericum  having  length  of  ~1.5  μm  and  diameter  of  ~0.5  μm
(Legendre et al. 2014). The other extreme, the smallest known virus which replicates
autonomously in cells is porcine circovirus type 1 (Mankertz et al. 1997; Tischer et al.
1974). The capsid of this virus is only ~17 nm in diameter, thus almost 90,000 copies of
the virus would be needed to form a line with a length corresponding to the pithovirus
size.
The mature infectious virus is referred as virion. Virions are macromolecular assemblies
that are found in wide variety of sizes, shapes and properties. However, in the simplest
form, virion contains only protein and nucleic acid: proteinaceous capsid encloses and
protects  the genome composed of  DNA or  RNA.  Capsid  proteins  mediate  their  self-
assembly. Besides of protecting the genome, capsid also mediates attachment and
entry to the host cell (Bhella 2018). Viral capsid has a metastable structure to be robust
enough to encounter extracellular phase, but also labile enough to allow the transfer
of the genome to the host cell to begin the new infection cycle.
Most of the known virion capsid morphologies so far fall into categories of icosahedral-
or helical viruses or to combination of these two (Caston and Carrascosa 2013)(Fig. 1).
Icosahedral capsid is formed from twenty facets assembled from capsid proteins
(Caston and Carrascosa 2013). Several icosahedral virions also carry spike or fibril
structures protruding from the virion surface. Helical viruses can be either filamentous
or rod shaped cylinders. They are formed, when capsid proteins are arranged side by
side in helical array to surround the genome, and the genome size determines the
4length of a helical virion (Stubbs and Kendall 2012). Variations of icosahedral and helical
viruses are abundant, but the underlying basic structure is the same (Fig. 1).
Combination of these two architectures is formed, when icosahedral head, enclosing
the genome, is attached to a helical tail. Head-tailed viruses may also include several
additional structures, such as a portal in the icosahedral head, collar connecting the tail
to the head as well as contractile structures in the tail (San Martin 2013). Icosahedral
as well as helical viruses are found to infect host cells from all three domains of life,
whereas head-tailed architecture is only met in bacteriophages and viruses of archaea.
There are also another diverse virus morphologies that do not fit into these categories.
They include, for example, droplet, bottle and bullet shaped virions. Especially viruses
infecting archaea represent a variety of morphotypes (Pietilä et al. 2014).
Figure 1. Schematic drawings of principal architectures of viruses. A) Icosahedral virus
structure, B) Helically symmetrical structure and C) Head-tailed virus, combination of
icosahedral and helical symmetry.
In addition to the basic architecture of the proteinaceous capsid and nucleic acid,
several viruses contain lipid bilayers either as an outermost envelope or inside the
capsid (Mäntynen et al. 2019). Yet another lipid bilayer containing virus morphotype is
pleomorphic virion. Instead of having a proteinaceous capsid, pleomorphic viruses
resemble lipid vesicles with randomly organized protein spikes embedded to the
envelope (Bamford et al. 2017). Lipid containing viruses acquire the lipid envelope from
host cell membranes (Welsch et al. 2007).
All components of the capsid are typically required for virions to be infective and the
integrity may be compromised in many ways, depending on the properties of the virion.
The proteinaceous capsid might be relatively robust, but to be infective, possible tails,
spike structures and lipid layers must be intact. Viruses are affected by changes in pH
5and ionic strength of the environment, which may lead into reversible or irreversible
changes in protein conformations and their interactions. Changes in the capsid proteins
can be detrimental. With several viruses, acidic pH in endocytic pathway induces
conformational changes leading to alterations in envelope fusion proteins. Thus,
applying low pH may induce premature changes in particles leading to alterations in
infectivity (Stegmann et al. 1987). In addition, aggregation of viruses would lead into
losses of infective viruses. Since lipids of the virion are typically involved in entry
processes (Poranen et al. 2002), distorted envelopes lead into loss of infectivity. Lipid
containing viruses are often inactivated by detergents and chemicals such as
chloroform, which was before extensively utilized to avoid bacterial contamination in
viral preparates (Mäntynen et al. 2019). In addition, lipid bilayer is not as robust
structure as protein capsid, thus it is more vulnerable for shear forces.
1.3. Prokaryotic viruses used in this study
In  this  work  two viruses  of  bacteria  and four  archaeal  viruses  were utilized (Fig.  2):
bacteriophages PRD1 and ?6 and archaeal viruses HVTV1, His1, HRPV1 and HCIV1.
1.3.1 Bacteriophages
Enterobacteria phage PRD1 is an icosahedral bacteriophage of Gram-negative bacteria
such as Salmonella (Olsen et al. 1974). PRD1 virion consists of proteinaceous
icosahedral capsid with diameter of ~66 nm that has ~20 nm spike structures at the
icosahedron vertexes. The capsid encloses internal lipid bilayer with embedded
membrane proteins (Fig. 2) (Abrescia et al. 2004; Cockburn et al. 2004). The replication
cycle of PRD1 is relatively short and progeny viruses are released via lysis in about 35
minutes post infection (Olsen et al. 1974). PRD1 has been extensively studied during
decades and has well established production and purification procedures (Bamford and
Bamford 1991).
Pseudomonas phage ?6, belonging to cystoviruses, is a virus of plant pathogenic
Pseudomonas (Vidaver et al. 1973). It has spherical shape with complex layered
structure including lipid envelope as an outer layer (Fig. 2). The envelope has proteins
embedded and spike structures protruding from it. The diameter of ?6 virion is ~85 nm
(Poranen et al. 2017). The next layer beneath the envelope is icosahedral nucleocapsid
composed of two concentric protein shells enclosing the genome (Sun et al. 2017). ?6
enters the host cell via membrane fusion in a similar manner to animal viruses (Bamford
et al. 1987) and exits the cell by lysis of the host cell in ~85 min post infection (Vidaver
et al. 1973).
61.3.2 Viruses of archaea
Haloarcula vallismortis tailed virus 1 (HVTV1) is a head-tailed virus of an archaea
Haloarcula vallismortis. HVTV1 has ~96 nm sized icosahedral head (vertex to vertex)
and ~73 nm long and flexible, non-contractile tail (Atanasova et al. 2012; Pietilä et al.
2013b). Virions of HVTV1 are released via host lysis after ~12 h post infection (Pietilä et
al. 2013b).
Haloarchaeal virus His1 is a spindle-shaped virus of Haloarcula hispanica (Bath and
Dyall-Smith 1998). Viruses with this morphotype are unique to archaeal hosts. His1
virion is ~44×77 nm in size with ~7 nm tails in one end. The capsid of His1 is elastic and
the capsid proteins have lipid modifications (Hong et al. 2015). The size of tails may
vary, thus the virus population might not always be homogenous (Hong et al. 2015;
Pietilä et al. 2013a). His1 virions are released without host cell lysis, but it causes
retardation of host growth (Bath et al. 2006).
Halorubrum pleomorphic virus 1 (HRPV1) was the first pleomorphic virus described for
archaea and to date the only archaeal virus carrying single-stranded DNA genome. The
size of HRPV1 is ~44×55 nm with randomly embedded glycosylated spikes that cause
heterogeneity to virus population (Pietilä et al. 2012; Pietilä et al. 2009). HRPV1 has a
non-lytic replication cycle (Pietilä et al. 2012).
Haloarcula californiae icosahedral virus 1 (HCIV1) has an icosahedral capsid enclosing a
lipid envelope. The capsid has horn-like spike structures at vertexes of the icosahedron
and the diameter of the capsid is ~70 nm. Virions are released via cell lysis ~12 h post
infection (Demina et al. 2016; Demina et al. 2017).
7Figure 2. Schematic morphologies of viruses utilized in this work. A: PRD1, B: ?6, C: HVTV1, D:
His1, E: HRPV1, F: HCIV1. Not in scale.
1.4. Prokaryotic virus life cycles
Typically the life cycle of prokaryotic viruses includes seven steps: attachment to host
cell surface, binding to the receptor, genome delivery, replication of viral genome,
synthesis of virion components, virion assembly and host cell lysis (Fig. 3). Binding to
the receptor is crucial and limiting step for the infection, since only cells displaying
receptor specific for certain virus, are susceptible for infection.
Binding  of  the  virion  to  the  receptor  initiates  series  of  events  that  lead  to  genome
delivery to the host cell. Host cell barriers that bacteriophages encounter are
peptidoglycan cell wall and one or two membrane bilayers. Several bacteriophages
deliver their genome to the bacterial cell through the helical tail structure (Fig. 2, Fig.
3) or through a special portal vertex of the icosahedral capsid (Poranen et al.  2002).
Cystoviruses are the only group of bacteriophages that have a lipid bilayer as an outer
envelope. In the case of cystovirus ?6, viral lipid envelope fuses with the host outer
membrane, peptidoglycan wall is then locally degraded by viral enzymes, and the virus
particle is finally internalized through the invagination of cytoplasmic membrane
(Bamford et al. 1987; Mindich and Lehman 1979; Poranen et al. 1999; Romantschuk et
al. 1988). The entry mechanisms of archaeal viruses are not well characterized yet, but
the apparent similarities to the counterparts in bacteriophages and viruses of
eukaryotes suggests similar strategies in their entry mechanisms (El Omari et al. 2019;
Pietilä et al. 2009). No matter how it is implemented, getting the viral genome inside
the cell is the essential step for every virus infection.
8When the genome is in the cell, virus begins to replicate the genome with the aid of
host factors or using viral polymerases. For successful replication, viruses need to hide
from host cells defense mechanisms such as restriction-modification and CRISPR/Cas-
system (Mojica et al. 2005; Seed 2015) and be able to hijack the control of the cell. This
is a delicate process where many functions of the cell are shut down, cellular factors
needed for replication and assembly are recruited, and cell is converted to a virus
factory  (Goodwin et  al.  2015).  After  the genome replication or  simultaneously  to  it,
virus begins to produce virion components which are then assembled. Virion capsid
may  be  assembled  on  top  of  the  genome  or  the  genome  may  be  packed  to  the
preformed procapsid after it has been assembled. Details of these steps are highly
variable between different viruses (Aksyuk and Rossmann 2011).
Replication cycle is finished when the new progeny viruses are released from the host
cell (Fig. 3). The release of virions may be lytic or non-lytic. In case of lytic release, cell
bursts and releases virions which were assembled in the cytosol. The release via lysis is
highly  regulated,  so  that  the  lysis  occurs  only  when  the  majority  of  virions  are
assembled and matured to encounter the cell exterior (Young 2014). Lytic cycle is
typical amongst bacteriophages. However, non-lytic cycle has been described for
pleomorphic viruses (Pietilä et al. 2009). In non-lytic cycle, virions are released from the
cell in continuous manner without bursting the host cell.
Instead of exiting the host, the life cycle of prokaryotic virus may turn to lysogenic cycle
(Fig. 3). In lysogenic life cycle virus establishes more or less permanent association with
the host cell. Thus, virus genome is inserted into host genome as a prophage or it exists
in the cell as an episome (Strömsten et al. 2003). Prophage replicates as a part of host
genome and is distributed to next cell generations (Ramisetty and Sudhakari 2019). The
lysogenic  cycle  may be reverted back to  lytic  one,  when beneficial  for  virus  survival
(Bobay et al. 2013; Nanda et al. 2015).
9Figure 3. Schematic presentation of lytic and lysogenic life cycle of a prokaryotic virus. The
infection may result in degradation of the host chromosome. Lytic cycle: 1. attachment, 2.
receptor binding, 3. genome delivery, 4. genome replication, 5. synthesis of virion components,
6. virion assembly and 7. host cell lysis. Lysogenic cycle proceeds from genome delivery to 4B.
prophage insertion and to 5B. cell division.
1.5. Virus purification
Virus research and different virus-based applications require highly purified viruses and
virus-like particles (VLPs). Since viruses can nowadays be propagated to large quantities
in bioreactors, the bottleneck step in providing viruses and VLPs for applications, has
shifted from production to purification processes (Nestola et al. 2015). Due to the fact
that viruses can only be propagated in living cells, the starting material for virus
purification is biologically complex. Cell lysate or the supernatant of infected cell
culture contains impurities derived from the host cells and growth media. Virus
infections are difficult to synchronize. Thus, the starting material may vary between
propagated batches depending on the growth conditions, the stage of infection, and
the growth phase of the cells. In most cases, all components of the virus particle need
to be intact to have infectious particle. Additional challenges to the virus purification
rises from the great variety of morphologies, sizes and other properties of viruses.
Several methods are typically needed and often used in different combinations to reach
the best outcome (Morenweiser 2005). However, the applied methods depend on the
intended use of purified viruses: is the highest possible yield or only extreme
homogeneity of virus preparation desired? Separation techniques may be based on
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different virus properties such as, size, shape, charge, density or sedimentation
(Nestola et al. 2015). Several methods are currently applied routinely in laboratories
and here I present the ones most important in context of this work.
1.5.1 Precipitation
Purification often begins with precipitation of viruses from the lysate, infected cell
culture or for example from dilute environmental sample. One of the most common
precipitation method used is precipitation with polyethylene glycol (PEG) and sodium
chloride (NaCl). PEG is a polymer that precipitates molecular complexes based on their
solubility. Precipitates are then easily removed from the original sample by
centrifugation (Fahie-Wilson and Halsall 2008; Yamamoto et al. 1970). Since the
precipitate can be dissolved in significantly smaller volume than the original sample,
this step is also important in concentrating the sample before next purification steps.
Indeed, PEG-precipitation in virus purification is typically considered as a concentrative
pre-step of the purification process. PEG precipitation is gentle, thus loss of biological
activity or protein denaturation does not typically occur (Asenjo and Andrews 2012).
Virus size and morphology determine the PEG concentration required for optimal
precipitation. However, precipitation with 10% PEG and 0.5 M NaCl is relatively
universal (Yamamoto et al. 1970). As a downfall of this method, PEG concentrates also
nucleic acids and other large complexes present in the starting material (Hagen et al.
1996).
1.5.2 Ultracentrifugation
Ultracentrifugation method is based on differences in sedimentation properties and
utilizes high speed and centrifugation force. In virus purification three methods of
ultracentrifugation are typically applied: rate zonal-, equilibrium-, and differential
ultracentrifugation. Rate zonal ultracentrifugation utilizes low density gradients and
separates viruses based on their shapes and sizes. In equilibrium centrifugation, higher
density gradient is applied and the separation is based on the differences in densities
of particles (Mohr and Völkl 2017). The gradients are typically comprised of sucrose or
cesium chloride (CsCl) which are hyperosmotic and viscose. This can be detrimental for
virions or to further applications. Gradient material may be removed with further
purification steps e.g. by differential centrifugation or by using buffer exchange devices
(Segura et al. 2006). Differential ultracentrifugation is utilized without gradient, to
harvest and concentrate viruses.
In ultracentrifugation viruses are exposed to high shear forces potentially leading into
aggregations and losses of biological activity. However, ultracentrifugation is routinely
utilized in virus purification. Acquiring larger amounts of viruses with
ultracentrifugation-based purification requires simultaneous access to several
11
expensive ultracentrifuges. Furthermore, preparing the gradients as well as loading and
unloading samples is laborious and time consuming.
1.5.3 Chromatography
Chromatography is defined as a separation technique where the sample is applied to a
stationary phase and eluted from it with the aid of mobile phase. Sample components
are stalled in the system by the stationary phase according to the characters of the
sample components and the stationary phase itself. Variety of different
chromatography techniques and sub techniques have been developed and are widely
used in the separation of biological and non-biological components. Even though
viruses are nanoscale entities, in the field of chromatography they are considered as
large macromolecular complexes leaving many traditional chromatography resins
inapplicable for the purification of viruses.
In virus purification, liquid chromatography utilizing size exclusion or ion exchange are
commonly applied methods. Size exclusion chromatography (SEC), as the name refers,
is a chromatographic separation method based on size. In SEC, the stationary phase
column is packed with porous beads. As the sample is applied on the column, small
sample components are retained, since they diffuse into the porous beads (Fekete et
al. 2014). Larger components, such as viruses, do not fit into the pores. Thus they elute
in the void volume before smaller ones. However, other large complexes present in the
sample are difficult to separate form viruses or VLPs with SEC (Andreadis et al. 1999).
Stationary phases more suitable for virus purification have been recently developed.
Monolithic convection interaction media matrices have continuous, sponge-like
structure, with cavities wide enough to allow viruses to enter. Monolithic stationary
phases in virus purification are mainly utilized in ion exchange chromatography
(Krajacic et al. 2017; Oksanen et al. 2012). Ion exchange chromatography is based on
electrostatic interactions, thus the sample components bind to the opposite charge
displayed in the monolith cavities. Elution may be achieved by changing the pH or by
increasing the ionic strength of the carrier solution. The elution with pH change is based
on the interplay with isoelectric point of the bound capsid proteins, thus by altering the
net charge and matrix binding capacity of the virus. Elution by increasing the ionic
strength of the carrier solution is based on addition of ions which compete of binding
and eventually displace the bound viruses (Cummins et al. 2011). Monolithic columns
have been applied in successful purification of viruses with different morphologies and
properties (Kramberger et al. 2010; Oksanen et al. 2012; Smrekar et al. 2011) and led
to high yields of purified, infective particles in short time. The elution with high ionic
strength carrier solution or by changing the pH may, however, compromise the
infectivity of labile virions. As the elution requires changes in ionic strength of the
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carrier solution, the infectivity of viruses requiring high salinity may be compromised.
However, viruses that tolerate lowered ionic strength for short periods of time may be
amenable for anion exchange chromatography.
1.5.4 Asymmetrical flow field-flow fractionation
In flow field-flow fractionation techniques, the separation is based on differences of
hydrodynamic sizes of the sample components. The separation is conducted with the
power of liquid flows without applying solid stationary phase. Flow field-flow
fractionation was introduced by Giddings in 1976 and a sub technique derived from it,
asymmetrical flow field-flow fractionation (AF4) was developed in 1987 (Giddings et al.
1976; Wahlund and Giddings 1987). The size-based separation in AF4 occurs in a thin
sample channel, which has sandwich-like composition (Fig. 4). The bottom wall of the
channel is a permeable frit which has an ultrafiltration membrane placed on top of it
forming the accumulation wall. The pore size of the membrane defines the molecular
weight cut of limit (MWCO) for the sample components – components smaller than
membrane pores flow through the channel bottom and only the larger ones are
retained for separation. Thin spacer positioned on top of the membrane determines
the thickness and the trapezoidal shape of the channel. The top layer of the channel is
a solid impermeable wall.
Figure 4. AF4 machinery, and the channel composition. A) AF4 machinery. The channel is
positioned in the temperature controlled oven (indicated with arrows). B) Assembled AF4
channel, C) The sandwich-like structure of the channel. Modified from figures of Postnova.
In AF4 analysis, the sample is injected to the channel along the incoming flow (flow in,
Fig. 5A). In the channel, there is a constant detector flow with parabolic profile that
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transports the sample components towards the outlet (flow out, Fig. 5A). However,
during the focusing step, the sample encounters an opposing focus flow which
concentrates the sample to a thin zone (Fig. 5B). Cross flow, perpendicular to detector
flow, is also applied and it drives the sample components towards the accumulation
wall that has the ultrafiltration membrane. Cross flow creates the flow field that
generates the separation power of AF4 (Wahlund and Giddings 1987). During the
focusing step, sample components are equilibrated to the channel according to their
hydrodynamic sizes. Due to diffusion, components migrate back against the cross flow
and eventually equilibrate to a certain distance from the membrane (Fig 5B). After this
focusing step, focus flow is switched off and the sample is let to elute from the channel
to detectors and fractionation, respectively (Fig. 5C). Detector flow has parabolic
profile, meaning that the flow rates are higher in the middle of the channel and lower
close to the walls. The smaller components diffusing further from the channel bottom,
reach higher flow rates and elute before bigger components (Wahlund and Giddings
1987).
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Figure 5. Schematic presentation of AF4 separation. A) Injected sample is carried to the channel
by the incoming flow (flow in). B) During focusing, the focus flow concentrates the sample to a
narrow zone C) Elution is achieved, when the focus flow is switched off and sample components
elute according to their hydrodynamic sizes, smaller ones first and larger ones later. AF4 channel
can be coupled to various detectors (at flow out) that enable data collection on concentration,
size and size distribution or fluorescence, depending on the detector(s). Photo courtesy of
Postnova.
In general, higher cross flow leads to later elution, as it hinders the diffusion of sample
components into higher detector flow velocities. Thus, cross flow is often programmed
to decline during the elution step to enhance the elution of larger components. The
elution program in AF4 is readily tailorable. One can choose to apply constant cross
flow or a gradient can be programmed to decay in step-wise, linear or exponential
manner (Fig. 6). Also the rate of cross-flow reduction can be adjusted.
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Figure 6. Possible elution programs in AF4 analysis. A) The linear reduction of cross-flow is
shown in red, step-wise in black and constant cross-flow in blue. B) The cross-flow rate can
also be altered exponentially.
The omission of the solid stationary phase in AF4 allows gentle separation to be
conducted without strong interaction or shear forces between sample and matrix. The
carrier solution may be selected according to the requirements of the sample.
However, great versatility due to the possibility to adjust several parameters might lead
to time consuming optimization of the conditions and requires understanding of the
theory behind the method (Gimbert et al. 2003). The MWCO and the material of the
membrane can be adjusted as well. The sample channel can be temperature controlled
and the flow rates and elution gradient is easily altered to reach optimal separation.
Several  detectors  such  as  UV-,  multi  angle  light  scattering  (MALS)-,  dynamic  light
scattering (DLS)- and fluorescence detectors can be connected to AF4, allowing real-
time data collection. In the normal mode AF4 is suitable for sample components with
sizes ranging between ~1?500nm. AF4 analysis is typically fast. Even though the AF4
theory is rather complicated, operating the AF4-interface is relatively simple.
AF4 has been widely applied in the studies of biological and non-biological
macromolecules as well as nanoparticles, their size distribution, aggregation as well as
interactions (Leeman et al.  2015). Viruses were one of the first objects studied with
AF4. They were applied to demonstrate the power of the technique in the
determination of the diffusion coefficients of particles and to study links between the
theory and practice of the method (Litzen 1993). Size, size distribution, dissociation,
stability and aggregations of viruses and VLPs have also been analyzed (Bousse et al.
2013; Chen et al. 2016; Eskelin and Poranen 2018; Lipin et al. 2008; Pease et al. 2009;
Wei et al. 2007). The purification in more preparative manner, however, has not been
studied before.
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1.6. Virus applications
Viruses are often called to be molecular machineries. Indeed, their natural properties
are routinely exploited in basic research, industry as well as in medicine and several
types of applications. Here I present examples of virus applications in medicine and
nanotechnology to showcase the innovations derived from virus research and to
highlight the motivation for production and purification of viruses and VLPs.
1.6.1 Medical applications
Emerging of multiresistant bacteria has led to intensive search for alternative medicine
and phage therapy has witnessed a renaissance. Antibiotics are no more effective
against all pathogenic bacteria and it has raised concerns of the possible epidemics with
pathogens that are currently held back by effective antibiotics. Indeed, the present
time is already referred as an advent of post antibiotic era (Lin et al. 2017). In phage
therapy, pathogenic bacteria are killed by applying strictly lytic bacteriophages specific
to the bacteria of interest (Gordillo Altamirano and Barr 2019). Since bacteriophages
are host specific, no damage to normal microbiota should occur and after host cells are
killed, no more phages are produced.  The emergence of commercially available broad
spectrum antibiotics during the Second World War collapsed the interest towards
phage therapy. However, Eliava institute in Georgia continued the phage therapy
studies and they have reported wide variety of successful case studies and collected
phage libraries during decades (Kutateladze and Adamia 2008). As the World Health
Organization (WHO) listed the fight against multiresistant bacteria as one of the most
important topics in research, also the rest of the world has re-adopted the phage
therapy in their research interests. Since current regulations in western countries are
heavily restricting the utilization of phage therapy, most of the data cumulates from
case-studies and from few clinical trials (Furfaro et al. 2018).
Due to the natural properties of viruses enclosing their genome in capsid and delivering
it to host cell in cell specific manner, viruses are of a high interest to be used as vectors
in gene therapy. In gene therapy, the goal is to replace malfunctioning gene of the
patient or to deliver a new gene which would be translated into therapeutic product by
the cell (Edelstein et al. 2004). Viral vector-based gene therapy is studied the most in
cancer treatment, where cancer cells can be addressed as targets for the vector. Also
monogenetic diseases are of a high interest. Delivering a functioning counterpart to
restore the function of impaired gene requires delivery to dividing stem cells (Ginn et
al. 2013). The research around viral gene vectors is blooming – around 2,600 clinical
trials have been approved between years 1989?2017, of which more than ~65% are
cancer related therapy and ~11% are for the treatment of monogenetic diseases (Ginn
et al. 2018). Viral vector based gene therapy against pathogenic diseases are also
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developed. The first viral vector-based gene therapy drug was accepted to the markets
in China in 2003. The vector is based on oncolytic adenovirus carrying human tumor
suppressor p53 gene (Peng 2005). Another viral vector-based gene therapy drug
exploiting human oncolytic herpes simplex virus 1 against melanoma, was released to
markets in U.S. and Europe in 2015 (Pol et al. 2015). In addition to viruses enclosing
genetic material, their capsid surface properties have been studied to be used in
medical purposes: bacteriophages have been applied to carry medical substances by
conjugating them to the capsid proteins via genetically or chemically engineered linker
(Hemminga et al. 2010). This technique could carry high therapeutic loads and release
it to high local concentrations. Viruses have also been proposed to be used as drug
enclosing nano carriers (Sunderland et al. 2017).
Vaccination against diseases is based on inducing protective immunity for the
vaccinated individual so that the adaptive immune system would recognize and
eliminate the same invading pathogen before the disease develops. Thus the
vaccination with whole pathogen or pathogen-derived antigens mimics the invading,
pathogen and activates immune system in a safe, pathogen-specific manner. The first
vaccination procedure was conducted against small pox by Edward Jenners in 1796.
The first real vaccines included whole killed pathogens and soon after attenuated living
viruses such as polio and rabies. Viruses were attenuated by passing them through
generations in non-human cells, until they lost the ability to cause infection in human
(Zepp 2010). Nowadays also VLPs that are self-assembled from viral capsid protein are
utilized in vaccines. VLPs typically lack the viral genome, yet their structure and antigens
resemble native viruses (Azevedo et al. 2013). Even though development of
vaccinations has been a huge triumph of medicine, the fast variability of virus antigens
causes continuous problems to keep the vaccines up to date. In the case of influenza
viruses,  the  prediction  of  circulating  viruses  has  to  be  made  a  half  year  before  the
upcoming influenza season to provide enough time for production and purification of
sufficient amount of vaccine components. Thus, more efficient processes would be
needed to accurately target the specific circulating viruses.
1.6.2 Nanotechnology
Nanotechnology is relatively young field of science, nevertheless, it has already led into
substantial discoveries of how to turn viruses and VLPs into a good use. The nanoscale
size and highly precisely arranged capsid structures have made viruses attractive
objects for nanomaterial development. As in gene therapy, the natural property of a
virus, to encapsulate cargo to the protein capsid, or cage, as nanotechnology often
refers to it, offers a possibility to encapsulate desired artificial cargo such as proteins,
inorganic nano particles as well as polymers into symmetric protein structures
(Koudelka et al. 2015; Uchida et al. 2018). VLPs are also utilized in biotemplating which
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applies metallization or mineralization of desired material on the inner or outer surface
of the capsid. Encapsulation and biotemplating has been utilized in a wide variety of
applications such as nanowires, imaging applications and in enzyme studies using virus-
derived nanoparticles as nanoreactors (Pokorski and Steinmetz 2011; Zhou et al. 2012).
In addition, nanotechnology has applied VLPs for tissue scaffolding, where they form a
biofilm enhancing proliferation and adhesion of the cells (Lin et al. 2008).
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2. AIMS OF THE STUDY
In this work, our goal was to explore the applicability of AF4 in virus purification. We
aimed also to evaluate the performance of AF4 in elevated salinities to extend the
method also for viruses requiring high ionic strength conditions to remain infective. Our
ultimate objective was to provide a novel virus purification method applicable for
different types of viruses and resulting in high yields and purity.
Another  aim  was  set  to  analytical  studies  of  viruses.  Since  the  purification  can  be
conducted after virus propagation, we wanted to develop AF4 method to monitor virus
production. The objective was to provide a rapid tool for optimization of virus
production.
The main aims of the study are summarized below:
1. To optimize AF4 conditions for efficient and rapid virus purification.
2. To expand the method to be applicable for different types of viruses.
3. To provide a tool for rapid monitoring of virus production and optimization of
conditions for virus propagation.
20
3. MATERIALS AND METHODS
Table 1. Summary of methods used in this work.
Method used in
Cultivation of prokaryote hosts I, II, III
Preparation of agar stocks and virus propagation in liquid culture I, II, III
Plaque assay I, II, III
Virus life cycle analysis I, II
Bradford assay for measuring protein concentration I, III
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE)
I, II, III
Coomassie blue staining of proteins I,II,III
Negative staining and transmission electron microscopy (TEM) II
Proteinase treatment of samples II
Nuclease treatment of samples I, II, II
Dynamic light scattering analysis (DLS) III
Multi angle light scattering analysis (MALS) I, II, III
Monolithic anion exchange chromatography I, III
Ultracentrifugation I,II,III
AF4 I,II,III
Table 2. Parameters adjusted or evaluated in AF4 method development
AF4 parameter
Membrane molecular weight cut off limit (MWCO)
Spacer thickness
Focusing step duration and flow rate
Cross flow rate and elution program
Detector flow rate
Linear working range
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4. RESULTS AND DISCUSSION
4.1 AF4 method development for virus purification
AF4 allows gentle separation of sample components of wide size range. However, there
are several parameters which can be adjusted for optimal separation. The effects of
these parameters are interconnected, having an effect on each other. Thus they all
need to be carefully considered and experimentally verified when developing a novel
purification method. In this work, samples applied as starting materials for purification
were infected culture supernatants, viruses precipitated from culture supernatant with
PEG and NaCl (PEG-virus) and viruses purified through PEG-NaCl precipitation,
subsequent rate-zonal and differential ultracentrifugation (1×virus).
4.1.1 Membrane
Several membrane materials for AF4 are available with different MWCOs. Membranes
are the potential sites for the interactions between sample components. Strong
attractive interactions between the virus and membrane might reduce the infectivity
of virions and yields of purified viruses as virions would be retained in the channel. On
the other hand, in case of repulsive interactions viruses might have access to higher
channel flow rates than expected by their sizes. This could lead to unexpected elution
behavior and to the early co-elution of viruses with smaller sample components
present in the input sample. Thus, the choice of membrane has to be carefully
considered.
Based on previous studies, bacteriophages ?6 and PRD1 were expected to have
negative surface charge (Block et al. 2014; Oksanen et al. 2012). As the regenerated
cellulose (RC) membrane has negative charge in neutral pH conditions (Bendixen et al.
2014) no attractive interactions were expected. In AF4, channel interactions are often
tested by repeated injections with and without cross-flow. The intensity, retention time
and shape of the peaks are compared to see any differences in the elution manner.
When developing the purification method for PRD1, repeated injections were
conducted without cross flow, and no difference in the intensity or peak shape was
observed (I). The A280 values of the peak regions were almost identical between
repetitions and similar when compared to the input sample. These results verified the
absence of attractive interactions. RC membrane has also previously been successfully
applied in studies of biological samples (Lang et al. 2009). The fact that high yields of
infective virions were obtained for all studied viruses indicate that no significant
interaction between the membrane and viruses occurred (Table 6; I, II, III).
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Table 3. Cross-flow rates in the beginning of the observed elution of studied viruses.
Virus sample* Cross flow rate (ml/min)** Reference
PRD1 ~0.2 I
?6 0 III
HVTV1 ~0.4 II
His1 ~0.1 II
HRPV1 ~0.4 II
HCIV1*** ~0.3 II
*Results are shown for purified lysates/culture supernatants when 350 μm spacer was used.
**Detector flow of 0.2 ml/min was applied for all viruses.
***HCIV1 was purified from agar stock.
Membranes with pore sizes of 10 kDa have been applied in analytical studies of viruses
and VLPs (Chuan et al. 2008; Citkowicz et al. 2008; Lang et al. 2009; Wei et al. 2007),
but in the context of purification, we predicted that 100 kDa MWCO would be
applicable. Pore size of 100 kDa would allow larger fraction of small components to
flow through the membrane. This would improve the separation especially with highly
complex samples. RC membranes with smaller pore size have higher pore density that
could possibly accommodate higher amount of the sample in the pores leading to
reduced yields (Ashby et al. 2014; Singh et al. 1998). In this work the absorbance (A260
or A280) values of the input culture supernatant and AF4 purified virus fractions were
compared and significant decrease was observed (I, II, III). This, in addition to high
yields, ~60?100%, of infective viruses obtained from the fractionation, showed that
most of host-derived impurities were removed, yet viruses were retained in the
channel for separation. Thus, the applicability of 100 kDa MWCO in virus purification
was confirmed.
4.1.2 Spacer
The spacer determining the channel shape, size, and volume affects the elution of
sample components. With thicker spacer, retention time increases, thus the duration
of the analysis is longer. Spacer of 350 μm has been utilized in most of the previous AF4
studies of VLPs and viruses (Chuan et al. 2008; Citkowicz et al. 2008; Lang et al. 2009;
Wei et al. 2007). In this study 350 μm spacer was also successfully applied to separate
viruses in the end of the cross flow gradient and smaller sample components in the
beginning the gradient (Table 3; I,II,III). This late elution of viruses was suitable in
context of this work, since viruses were expected to be the largest components present
in the starting material.
When the channel thickness is small, less diffusion is required to reach flow rates high
enough for elution. Thus, larger sample components elute during the cross flow
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gradient, which empowers their separation. Consequently, thinner spacer allows faster
analysis because of reduction in the retention time. In this work spacer of 250 μm was
applied in the life cycle analysis of PRD1 and His1 (I, II). As expected, the thinner spacer
resulted in decreased retention time of the virus and the elution occurred during higher
cross-flow rates than when purification was conducted with the 350 μm spacer and
same elution program was applied. The retention time of PRD1 decreased by ~13 min
and elution shifted from ~0.2 to ~0.7 ml/min cross flow (table 3; I). In the case of His1,
virus elution begin at ~0.6 ml/min, whereas it was ~0.1 ml/min when virus was purified
applying the 350 μm spacer (Table 3; II). Applying thinner spacer also decreased the
consumption of carrier solution. Spacer of 250 μm has recently been applied in
controlled dissociation studies of ?6, also resulting in virus elution during the cross flow
and enabling the separation from larger complexes if present in the samples (Eskelin
and Poranen 2018).
Dilution is a known drawback of AF4 that can be tackled with using thin spacer. When
the 350 μm spacer was applied, ~seven-fold dilution occurred in the purification of
PRD1 lysate, ~2-fold with HVTV1, His1 and HCIV1, but no dilution with bacteriophage
?6 lysate.  PEG-  and 1×viruses  diluted more than low purity  input  samples  (I,  II,  III).
When the 250 μm spacer was applied in life cycle studies of PRD1 and His1, less dilution
occurred (I, II). There is another ways to reduce dilution. Majority of the channel
volume is free of sample components, as they accommodate only ~1 μm layer above
the membrane. Thus, an additional pump separating the sample-free flow can be
applied (Prestel et al. 2006). Also careful fractionation reduces sample dilution.
4.1.3 Carrier solution and the effect of high ionic strength
Carrier solution (mobile phase) affects the interactions between sample components
as well as between sample and the membrane. In low ionic strength conditions,
electrostatic interactions are dominant, whereas higher ionic strength shields
electrostatic repulsion, enhances hydrophobic interactions and thus allows sample
components to equilibrate closer to the membrane resulting in later elution (Mudalige
et al. 2017; Wagner et al. 2014b).
The data available on the carrier solution effects in AF4 is limited to relatively low, 75?
150 mM, ionic strengths (Benincasa and Caldwell 2001; Neubauer et al. 2011; Wagner
et al. 2014b). In this work neutral pH carrier solutions of low (2 mM), medium (0.6 M)
and high (1.6 M) ionic strength were applied to evaluate the elution of standard
proteins with acidic pI values and sizes ranging from 150 to 669 kDa as well as PRD1
with  size  of  66  MDa  (II).  Ionic  strengths  were  tested  with  two  combinations  of
membrane and spacer (Table 4).
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Table 4. Combinations of carrier solutions, membrane MWCO and spacer tested.
 x = Ionic strength tested with the membrane and spacer combination in question.
With both membrane-spacer combinations and with all tested samples, higher ionic
strength carrier solution increased the retention time as was expected. In case of the
100 kDa membrane and the 350 μm spacer, the change in the retention time was larger
and peaks were slightly broader with the higher ionic strength buffer. Interestingly,
when the combination of 100 kDa membrane and 350 μm spacer was applied with
medium 0.6 M carrier solution, no signal for alcohol dehydrogenase of 150 kDa was
detected. Nevertheless, with 2 mM carrier solution the protein was observed (II). Since
the size  of  alcohol  dehydrogenase is  somewhat  close to  the 100 kDa pore size,  it  is
plausible that higher ionic strength environment induced conformational changes in
the protein, thus allowed it to pass through the membrane. Indeed, with the membrane
and spacer combination of 10 kDa and 250 μm, alcohol dehydrogenase was observed
also with medium and high ionic strength carrier solutions. Therefore, MWCO of the
membrane should be carefully considered if high ionic strength is applied in the analysis
of sample that contains components with sizes close to the MWCO. In addition to
standard proteins, we also tested these carrier solutions with PRD1 and the
combination of 10 kDa and 250 μm spacer. Similarly to standard proteins, the retention
time of PRD1 increased when the ionic strength was higher.
In conclusion, also higher ionic strength carrier solutions are applicable for AF4. The
results with PRD1 and halophilic viruses showed no disadvantages in applying elevated
salinity for virus purification with AF4 (I, II). This is especially important when viruses,
which are adapted to high ionic strength environments are purified, since their
infectivity may be lost in low salinity. It is also noteworthy, that viruses tested in this
work, did not elute solely according to their sizes, for example icosahedral PRD1 with
diameter of 66 nm elutes with lower cross flow than HVTV1 with ~76×96 nm head and
73 nm tail. This indicates that the sample nature and salinity of the carrier solution
affected the elution (Table 3). This furthermore highlights that the ionic strength of the
carrier solution should be optimized.
Total ionic strength of the
carrier solution
Membrane and spacer combination
10 kDa + 250 μm 100 kDa + 350 μm
Low (2 mM) not tested x
Medium (0.6 M) x x
High (1.6 M) x not tested
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4.1.4 Elution program design
Besides membrane and spacer, the elution program for viruses was optimized. This
included adjusting focusing step, detector- and cross flow rates as well as elution
gradients. Also the linear working range was determined.
4.1.4.1. Focusing step
Before elution begins, sample components need to be equilibrated in the channel to
enable them to elute according to their sizes. This is conducted by applying the focusing
step to the AF4 method (Wahlund and Giddings 1987). As sample components are
concentrated to a narrow zone during focusing and pushed towards the membrane,
interactions between sample components and between the sample and the membrane
may be enhanced. Consequently, extensive focusing may cause increased retention
time, reduced yields and induce aggregation (Wahlund 2013). On the other hand,
proceeding to the elution program before properly equilibrating the sample, leads to
increased elution of the sample in the void and to reduced separation power (Wagner
et al. 2014a).
To optimize the focusing step for virus purification, PEG-precipitated PRD1 sample
(PEG-PRD1) was analyzed by applying focusing step of 5, 10 and 15 min with cross flow
of  1  ml/min.  Elution  was  performed  with  linearly  decaying  cross  flow  gradient  and
resulted in a fractogram with a low intensity peak and more intense second peak. No
difference in the intensity or separation of these two peaks was observed between
different focusing times. However, the void peak was smaller and better separated
when 10 or 15 minutes of focusing was applied (I). As this method was intended to be
applied for more complex input samples and large sample amounts, the void needed
to be as small as possible without compromising the yields and purity. In general, the
obtained high yields of infective viruses and the homogeneity of virus particles
indicated that no irreversible sample retention in the channel or aggregation due to 10
or 15 min focusing occurred (I, II, III). In previous studies, focusing time of 15 minutes
has been shown to be suitable for influenza virus (Wei et al. 2007).
4.1.4.2. Flow rates and gradients
Cross flow has the major effect on retention and elution of the sample components.
Cross  flow  rates  of  0.5,  0.75,  1.0  and  1.5  ml/min  with  15  minutes  linearly  decaying
gradient to 0.1 ml/min were compared when developing the method with PEG-PRD1
(I). The applied detector flow was 0.2 ml/min. The intensity of the virus peak was low
and the shape wide with 0.5 ml/min cross flow rates, suggesting that 0.5 ml/ml cross
flow was not high enough for PRD1 to be sufficiently retained in the channel. High cross
flow  drives  the  sample  components  to  close  proximity  of  the  membrane  and  may
enhance membrane-sample and sample-sample interactions. In case of 0.75, 1.0 and
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1.5 ml/min flow rates, peaks were similar in shape, thinner and more intense. The
difference in the retention time between the lowest and the highest cross flow was ~3
min as measured from the top of the peak. Too high cross flow is connected to dilution
of the sample as well as to peak broadening (Wei et al. 2007). Large components are
especially prone for dilution (Kok and Qureshi 2010). Molecules with different shapes
require different cross flows to be retained in the channel for sufficient separation.
Based on the intensities of peaks the highest applied cross flow did not induce
significant dilution. Globular molecules, due to their dense conformation, require
rather high cross flows, whereas more expanded conformations have lower diffusion
coeffiences and are retained in the channel with lower cross flows (Wittgren and
Wahlund 1997).
Two combinations of detector- and cross flows were compared with PEG-PRD1: 0.2 and
0.5 ml/min as well as 1.0 and 1.5 ml/min, respectively (I). All combinations resulted in
high yields of infective viruses (61?82 %). Of all combinations tested, detector flow of
0.2  ml/min  combined  to  cross  flow  of  1.0  ml/min  led  to  the  best  purity  of  ~5×1011
plaque forming units PFU/A280. The corresponding value of the input sample was
~1×1011 PFU/A280. With these experiments we defined that detector flow of 0.2 ml/min
and cross flow of 1.0 ml/min were suitable for virus purification and successfully
applied them to other five viruses as well (I, II, III) (chapter 4.2).
In this work we tested elution programs with step wise or linearly decaying cross flow
(I, II, III). Lysates and culture supernatants were known to contain sample components
of a wide size range. Thus the elution program needed to be designed so that the
resolution between other sample components and large viruses would be high enough.
The highest purity level, according to specific infectivity, was obtained with linearly
decaying cross-flow gradient (I). Due to the relatively large size of viruses, they are well
retained in the channel and elute at low cross-flows. PRD1 eluted at low cross flow rate
(0.2 ml/min) and resulted in high yields of infective viruses (Table 3, Table 5). Similar
results were observed with all viruses studied in this work (Table 3, Table 5).
4.1.4.3 Working range
One main questions when a purification method is developed is the efficacy and one
important parameter defining it is the amount of sample that can be purified at the
time. In AF4, the channel overloading occurs if sample components cannot be
accommodated to the correct equilibrium position in the channel because of high
concentration of similarly sized components. Sample ends up in higher channel
velocities and elutes early. Overloading is typically observed as broadening of the peaks
(Caldwell et al. 1988; Hupfeld et al. 2009; Wiedmer and Yohannes 2012).
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In this work, analytical AF4 channel and preparative UV-detector were applied. The
linear working range of AF4 with PRD1 was explored by applying the 350 μm spacer,
100 kDa RC membrane and pre-purified PRD1 as a series of ten-fold dilutions from 0.3
μg  to  3,300  μg.  UV  signal  from  0.3  μg  injection  was  poorly  separated  from  the
background signal. When 3,300 μg of virus was injected to the channel, the peak
showed slight distortion, thus the upper limit with these elution conditions were
reached. When 8800 μg of virus was applied, the peak broadening and spiky
appearance was observed. The linear working range was defined to be wide: ~1 μg ?~3
mg of virus which equals 1.4×109?1.4×1013 PFU (I).
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4.2 Virus purification results
When the performance of AF4 in virus purification was explored, infectivity of obtained
viruses  as  well  as  purity  level  and  the  yield  of  purified  viruses  were  evaluated.  AF4
purification was compared to the PEG-NaCl and ultracentrifugation -based purification
method (Fig. 7).
Figure 7. Workflow of PEG-NaCl precipitation and ultracentrifugation -based virus purification
compared to virus purification with AF4. Presented duration estimates may slightly vary
depending on a virus.
4.2.1. Virus integrity
In this work, integrity of AF4 purified viruses was assessed through infectivity. Since AF4
does not have the solid stationary phase and applied elution conditions were optimized
for viruses using virus specific buffers (see previous chapters), no strong interactions
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were expected to occur and virus integrity was predicted to be maintained. Indeed all
six viruses maintained their infectivity throughout the AF4 fractionation. Importantly,
high specific infectivities were observed for all viruses, independently of the purity level
of the input sample (I, II, III). Thus, high purity viruses can be obtained from crude cell
lysates or culture supernatants. Furthermore, analyses of the AF4 purified virus
samples by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) confirmed the
presence of all the structural protein subunits in correct rations (I, II, III).
4.2.2. Purity of AF4 fractionated viruses
The purity of AF4 purified viruses was mainly assessed through the specific infectivities
of collected virus preparates. The specific infectivity values were formed as a ratio of
plaque forming units (PFU) to milligrams of protein or to an absorbance value (A260 or
A280) of the preparates. Due to size based AF4 fractioning and flow of components
smaller than 100 kDa through the membrane the total amount of protein or the
absorbance value of fractions was lower in AF4 fractionated virus preparates than in
the input sample.  The reduction in total protein amount was significant especially with
when lower purity level inputs were fractionated.
When the pre-purified 1×virus was subjected to AF4 purification, the improvement of
the specific infectivity was insignificant for most of the viruses. Further purification
from 1×virus input was observed only for HVTV1, revealing ~5-fold higher specific
infectivity after AF4 purification (II). When PEG-precipitated viruses were purified with
AF4, improvement in specific infectivities ranged between 3 to 8-fold. The highest
improvement  in  purity,  10  to  140-fold,  was  observed  for  the  least  purified  starting
materials, lysates and culture supernatants (Table 5). Purification of HCIV1 utilizing agar
stock as starting material resulted in ~8-fold improvement in purity level (II; Table 5).
The important observation here was that regardless of the starting material used for
purification, the specific infectivity in AF4 purified preparates were similar. Thus crude
virus samples are highly applicable for AF4 purification. When AF4 purification of PRD1
(I), ?6 (III) and HRPV1 (II) was conducted with in-line MALS and DLS detectors, particles
in the peak fractions were observed to be homogenous in size, thus no aggregations
co-eluted with AF4 purified virus preparates (I, II, III).
SDS-PAGE analysis of protein contents in purified virus fractions verified the numeric
data. Vast majority of protein impurities present in input samples were observed in
fractions eluting in the beginning of the elution gradient. Protein patterns typical for
each virus were dominant in virus fractions where only few protein impurities were
present.   Purity  level  of  HRPV1  was  also  visually  monitored  through  electron
microscope (II). Virus shape and size correlated with published data (Pietilä et al. 2009)
but filamentous material was observed to co-purify with viruses
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Table 5. Relative purity of AF4 fractionated virus samples compared to the input
material
Improvement in purity*
lysate/culture
supernatant
PEG-virus 1×virus
PRD1 10 7 0
?6 140 5 0
HVTV1 24 3 0
His1 60 8 5
HRPV1 60 3 0
HCIV1 8** not tested not tested
*Purity measured as specific infectivity
**HCIV1 was purified from agar stock.
4.2.3 Yields of infective viruses
Precipitation and ultracentrifugation based purification of viruses with well-established
methods used in this project, led into yields varying between ~3 ?~27% depending on
the virus (Table 6). The total yield of infective viruses from AF4 fractionated 1×viruses
ranged between 70?100%,  and with PEG-viruses  40?100 % (Table  6).  In  the case of
lysate or culture supernatants, the yields of infective viruses were between ~60 and
~100 %. Thus in all cases the obtained yield was higher than with the traditional method
(Table 6). The yield of HCIV1 purified from agar stock was ~35%. That was lower than
the typical ~44% yield obtained from lysate by utilizing precipitation-
ultracentrifugation (Table 6). Agar stock may need pre purification to reduce viscosity
before AF4 fractionation.
The microgram amount of virus-specific proteins obtained from the AF4 purification
were determined for PRD1 and ?6. Virus fractions of halophilic viruses contained such
high salinity that Bradford protein concentration measurement was not applicable. In
the case of PRD1, ~12 μg of virus protein was obtained from 0.5 ml of lysate, whereas
with ?6 ~40 μg of virus protein was collected from 1 ml of lysate. In contrast, ~1 mg of
PRD1 and ~7 mg of ?6 virus protein was obtained from 1 l of lysate with precipitation
and ultracentrifugation based purification method (Table 7, Fig.7, I, III). Even though
protein amounts obtained from a single ~1h AF4 purification were low, the yield can be
increased by repeated fractionations and by applying larger sample volumes. If 5 ml
injections would be applied on PRD1 and ?6, equal milligram amounts would be
obtained with 9 and 35 AF4 runs corresponding to 45 and 175 ml of lysate, respectively
(Table 7). According to the working range determined for PRD1 (see chapter 4.1.3.3.),
the low protein concentrations in PRD1 and ?6 lysates suggests, that 5 ml injections
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could be conducted (I, III). HRPV1 was purified from 5 ml of culture supernatant (II).
AF4 can also be run in semi-preparative mode utilizing repeated, automatic injections,
and semi-preparative channel allowing fractionation of larger lysate volumes and
upscaling the method. This will be tested in near future.
Table 6. Precentual yields of infective viruses from the purification with traditional
precipitation-ultracentrifugation and AF4.
*Yields calculated from combined fractions of the virus peak area.
**N.D = not determined
***Demina et al., 2016
Table 7. Comparison of predicted virus yields from different volumes of starting
material applying precipitation-ultracentrifugation method and AF4-purification.
Purified Sample PRD1 lysate ?6 lysate
Method applied PEG-UC* AF4 PEG-UC* AF4
Yield of viruses (mg) ~1 ~1 ~7 ~7
Volume of the starting material (ml) 1000 45 1000 175
*PEG-UC = precipitation-ultracentrifugation method
4.3 Life cycle analysis
Before any detailed research on virus structure or function can be done, they need to
be produced and purified. Optimization of production conditions of new viruses takes
time and effort. The infection cycle is conventionally studied by one step growth
experiment where the turbidity of the infected culture is monitored (Ellis and Delbrück
1939). If viruses are released via lysis, the turbidity of the culture collapses dramatically,
whereas  in  case  of  non-lytic  infection  cycle,  virus  release  goes  unnoted  since  cells
remain intact and turbidity does not decrease. One step growth experiment is often
combined with the plaque assay to see when the amount of free phages is the highest.
Virus Precipitation-
ultracentrifugation
AF4* Reference
lysate/culture
supernatant
PEG
precipitated
virus
1×virus
PRD1 ~18 ~60 ~40 ~70 (I)
?6 ~27 ~100 ~100 ~70 (III)
HVTV1 ~3 ~60 ~65 ~80 (II)
His1 ~7 ~85 ~90 ~100 (II)
HRPV1 ~11 ~70 ~100 ~70 (II)
HCIV1 ~44** ~35 N.D.** N.D.** (II)
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However, this approach is requires lots of sampling. This is especially time consuming
when working with slowly growing hosts, such as halophilic archaea, which often need
~two days for a single one-step growth assay and 3?6 days for the plaque assay.
We monitored samples from the one step growth assays of a lytic bacteriophage PRD1
and non-lytic His1 (I,  II)  by AF4 to see if it  could be utilized to optimize virus growth
conditions. Samples from the infected cultures were analysed from different time
points to observe virus release to the growth media (I, II). In both cases the uninfected
host culture were also analysed to distinguish any changes derived from the virus
infection. The release of new virions appeared as a new peak appeared in the
fractograms. This was verified by the plaque assay. Since PRD1 is a lytic virus, the
release  of  cell  contents  was  seen  in  the  AF4  fractogram  concurrently  to  virus
appearance as wide and intense peak in the beginning of the elution gradient. As the
infection proceeded the peak for contaminants was reduced. When the infection cycle
of His1 was analyzed, the virus release was observed only 24 h after infection. Since
His1 is a non-lytic virus, release of cell contents was not seen in the fractogram as
clearly as it was with PRD1.
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5. CONCLUSIONS AND FUTURE PERSPECTIVES
In this work, a novel virus purification method based on AF4 was developed and
compared to traditional method based on precipitation and ultracentrifugation. To our
knowledge this is the first attempt to utilize AF4 in virus purification, even though AF4
has been applied in virus analysis before. Six viruses with different morphologies,
biochemical and biophysical properties were applied for AF4 purification. Four of the
viruses required elevated salinity to maintain their infectivity. All viruses remained
intact and infective throughout the AF4 fractionation and yields of infective viruses
were high.
The purity of AF4 fractionated viruses, measured as specific infectivity was comparable
to that obtained with the traditional method. Importantly, the obtained specific
infectivity values were similar irrespectively of the starting material. Crude samples
such as lysates and infected culture supernatants can be applied as starting materials
in AF4 purification, streamlining the multi-step purification process (Fig. 7). Applying
dilute, low purity level starting material is also encouraged by the fact that no dilution
occurred with these samples. Since lysates and culture supernatants are dilute, higher
injection volumes would be applicable. Utilizing larger volumes, automatic reinjections
and thicker spacer or semi-preparative sample channel, would allow faster purification
of milligram amounts of viruses. High virus yields from AF4 purification would
significantly reduce the amounts of required starting material, thus leading to lower
costs of virus production (Table 7). For example, in case of the enveloped bacteriophage
?6 purification, 6-times less starting material would be needed to obtain as much
viruses as was obtained with traditional method.
AF4 was also proven to be suitable for life cycle analysis of lytic and non-lytic viruses.
The release of progeny viruses to the growth media was observed by applying rapid
~45 min elution program. Thus, AF4 could be applied in the optimization of virus growth
conditions. This would omit the need for massive plaque assays on the samples
collected from different conditions and phases of infection.
Now that the step towards semi-preparative scale virus purification with AF4 has been
taken and the starting point is established, the method can be further explored and
developed for other viruses. Since the developed method is highly tailorable, it can also
be applied in virus analytics.
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